3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Gastrointestinal Stromal Tumors
71
Sarcoma
12
Brain Neoplasms
10
Gliosarcoma
9
Glioblastoma
9
Neoplasm Metastasis
6
Glioma
6
Dermatofibrosarcoma
6
Oligodendroglioma
5
Central Nervous System Neoplasms
5
Astrocytoma
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Fibrosarcoma
4
Chordoma
4
Sarcoma, Synovial
3
Osteosarcoma
3
Neurofibrosarcoma
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Neoplasms
3
Liposarcoma
3
Hemangiosarcoma
3
Glioma, Subependymal
3
Digestive System Neoplasms
3
Desmoid Tumors
3
Sarcoma, Endometrial Stromal
2
Recurrence
2
Primary Myelofibrosis
2
Piebaldism
2
Multiple Myeloma
2
Meningioma
2
Interventions
Cyclophosphamide
3
tislelizumab
1
spartalizumab
1
pembrolizumab
1
montanide ISA 51
1
entinostat
1
Thrombopoietin
1
LY2940680
1
Interleukin-2
1
Immunologic Techniques
1
Imatinib Mesylate
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cryosurgery
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Imatinib Mesylate
×
Sarcoma
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled